Lead party: Verge HealthTech Fund (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: VitruvianMD
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Ordinary Shares (Equity)
Lead investor/buyer: Verge HealthTech Fund · Investors/buyers: Verge HealthTech Fund, Angel Investors
Legal advisers: not identified in the source record.
Source: announced 20 August 2021. Original announcement: old.disruptafrica.com.


